Press Releases

SECAUCUS, N.J., July 17, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best Places to Work for Disability Inclusion" by Disability:IN and the American Association of People with Disabilities (AAPD). 

NEW YORK, July 17, 2019 /PRNewswire/ -- Senior Helpers®, one of the nation's premier providers of personalized in-home senior care, revealed today that

Truverra's Health Canada licensed facility in Toronto, ON to produce cannabis derivative products for Legalization 2.0. Truverra to serve as Supreme Cannabis' global medical brand, building on existing R&D platform and established CBD offering in Europe. Skilled management team with decades of domestic and international experien

CUPERTINO, Calif., July 17, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged that the submission of DURECT's full response to the Complete Response Letter (CRL) it previously received from FDA related to POSIMIR® (bupivacaine extended-release solution) is consider

Tool that uses smartphone camera to be rolled out to clinicians this year TORONTO, July 17, 2019 /PRNewswire/ -- Inner Analytics announced today the launch of it

MEMPHIS, Tenn., July 17, 2019 /PRNewswire/ -- St. Jude Children's Research Hospital® and ALSAC, the fundraising and awareness organization for St. Jude, today anno

LONDON, July 17, 2019 /PRNewswire/ -- Huntsworth PLC (LSE: HNT) (www.huntsworth.com), an international healthcare and communications group, announced the appointment of

LEVERKUSEN, Germany and BOSTON, July 17, 2019 /PRNewswire/ -- Pyxis Oncology ("Pyxis"), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor microenvironment. Leaps by Bayer led the Company's

WOONSOCKET, R.I., July 17, 2019 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the initiation of a clinical trial designed to evaluate the safety and efficacy of the HemoCare™ Hemodialysis System for administration of home hemodialysis. The innovative device includes safety features and is designed to make home hemodialysis simple for patients. Home hemodi

SAN DIEGO, July 17, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that argenx has dosed the first subject in a phase 1 clinical trial evaluating the safety, pharmacokinetics and pharmacodynamics of efgartigimod (ARGX-113), using Halozyme's proprietary E